Search results
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant...
Benzinga· 2 days agoBeyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease